199 related articles for article (PubMed ID: 24696448)
1. IRAK-M deficiency promotes the development of type 1 diabetes in NOD mice.
Tan Q; Majewska-Szczepanik M; Zhang X; Szczepanik M; Zhou Z; Wong FS; Wen L
Diabetes; 2014 Aug; 63(8):2761-75. PubMed ID: 24696448
[TBL] [Abstract][Full Text] [Related]
2. Downregulated NLRP3 and NLRP1 inflammasomes signaling pathways in the development and progression of type 1 diabetes mellitus.
Liu H; Xu R; Kong Q; Liu J; Yu Z; Zhao C
Biomed Pharmacother; 2017 Oct; 94():619-626. PubMed ID: 28783585
[TBL] [Abstract][Full Text] [Related]
3. Activation-induced cytidine deaminase deficiency accelerates autoimmune diabetes in NOD mice.
Tan Q; Tai N; Li Y; Pearson J; Pennetti S; Zhou Z; Wong FS; Wen L
JCI Insight; 2018 Jan; 3(1):. PubMed ID: 29321370
[TBL] [Abstract][Full Text] [Related]
4. IRAK-4 kinase activity is required for IRAK-4-dependent innate and adaptive immune responses.
Lye E; Dhanji S; Calzascia T; Elford AR; Ohashi PS
Eur J Immunol; 2008 Mar; 38(3):870-6. PubMed ID: 18286567
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse.
Gallichan WS; Balasa B; Davies JD; Sarvetnick N
J Immunol; 1999 Aug; 163(3):1696-703. PubMed ID: 10415077
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-1 receptor-associated kinase-M suppresses systemic lupus erythematosus.
Lech M; Kantner C; Kulkarni OP; Ryu M; Vlasova E; Heesemann J; Anz D; Endres S; Kobayashi KS; Flavell RA; Martin J; Anders HJ
Ann Rheum Dis; 2011 Dec; 70(12):2207-17. PubMed ID: 21875872
[TBL] [Abstract][Full Text] [Related]
7. IL-12 administration accelerates autoimmune diabetes in both wild-type and IFN-gamma-deficient nonobese diabetic mice, revealing pathogenic and protective effects of IL-12-induced IFN-gamma.
Trembleau S; Penna G; Gregori S; Giarratana N; Adorini L
J Immunol; 2003 Jun; 170(11):5491-501. PubMed ID: 12759426
[TBL] [Abstract][Full Text] [Related]
8. Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice.
Nakayama M; Abiru N; Moriyama H; Babaya N; Liu E; Miao D; Yu L; Wegmann DR; Hutton JC; Elliott JF; Eisenbarth GS
Nature; 2005 May; 435(7039):220-3. PubMed ID: 15889095
[TBL] [Abstract][Full Text] [Related]
9. Insulin-producing intestinal K cells protect nonobese diabetic mice from autoimmune diabetes.
Mojibian M; Lam AW; Fujita Y; Asadi A; Grassl GA; Dickie P; Tan R; Cheung AT; Kieffer TJ
Gastroenterology; 2014 Jul; 147(1):162-171.e6. PubMed ID: 24662331
[TBL] [Abstract][Full Text] [Related]
10. Induction of Tolerogenic Dendritic Cells by a PEGylated TLR7 Ligand for Treatment of Type 1 Diabetes.
Hayashi T; Yao S; Crain B; Promessi VJ; Shyu L; Sheng C; Kang M; Cottam HB; Carson DA; Corr M
PLoS One; 2015; 10(6):e0129867. PubMed ID: 26076454
[TBL] [Abstract][Full Text] [Related]
11. Curcumin ameliorates autoimmune diabetes. Evidence in accelerated murine models of type 1 diabetes.
Castro CN; Barcala Tabarrozzi AE; Winnewisser J; Gimeno ML; Antunica Noguerol M; Liberman AC; Paz DA; Dewey RA; Perone MJ
Clin Exp Immunol; 2014 Jul; 177(1):149-60. PubMed ID: 24628444
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-15 plays an essential role in the pathogenesis of autoimmune diabetes in the NOD mouse.
Bobbala D; Chen XL; Leblanc C; Mayhue M; Stankova J; Tanaka T; Chen YG; Ilangumaran S; Ramanathan S
Diabetologia; 2012 Nov; 55(11):3010-20. PubMed ID: 22890824
[TBL] [Abstract][Full Text] [Related]
13. A mechanism for IL-10-mediated diabetes in the nonobese diabetic (NOD) mouse: ICAM-1 deficiency blocks accelerated diabetes.
Balasa B; La Cava A; Van Gunst K; Mocnik L; Balakrishna D; Nguyen N; Tucker L; Sarvetnick N
J Immunol; 2000 Dec; 165(12):7330-7. PubMed ID: 11120869
[TBL] [Abstract][Full Text] [Related]
14. In vivo diabetogenic action of CD4+ T lymphocytes requires Fas expression and is independent of IL-1 and IL-18.
Wen L; Green EA; Stratmann T; Panosa A; Gomis R; Eynon EE; Flavell RA; Mezquita JA; Mora C
Eur J Immunol; 2011 May; 41(5):1344-51. PubMed ID: 21469125
[TBL] [Abstract][Full Text] [Related]
15. Neutrophils Deficient in Innate Suppressor IRAK-M Enhances Anti-tumor Immune Responses.
Zhang Y; Diao N; Lee CK; Chu HW; Bai L; Li L
Mol Ther; 2020 Jan; 28(1):89-99. PubMed ID: 31607540
[TBL] [Abstract][Full Text] [Related]
16. Dysregulated B7-1 and B7-2 expression on nonobese diabetic mouse B cells is associated with increased T cell costimulation and the development of insulitis.
Hussain S; Delovitch TL
J Immunol; 2005 Jan; 174(2):680-7. PubMed ID: 15634886
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-1 receptor associated kinase (IRAK)-M -mediated type 2 microglia polarization ameliorates the severity of experimental autoimmune encephalomyelitis (EAE).
Liu B; Gu Y; Pei S; Peng Y; Chen J; Pham LV; Shen HY; Zhang J; Wang H
J Autoimmun; 2019 Aug; 102():77-88. PubMed ID: 31036429
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-1 receptor-associated kinase 4 is essential for initial host control of Brucella abortus infection.
Oliveira FS; Carvalho NB; Brandão AP; Gomes MT; de Almeida LA; Oliveira SC
Infect Immun; 2011 Nov; 79(11):4688-95. PubMed ID: 21844234
[TBL] [Abstract][Full Text] [Related]
19. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice.
Noorchashm H; Lieu YK; Noorchashm N; Rostami SY; Greeley SA; Schlachterman A; Song HK; Noto LE; Jevnikar AM; Barker CF; Naji A
J Immunol; 1999 Jul; 163(2):743-50. PubMed ID: 10395666
[TBL] [Abstract][Full Text] [Related]
20. IRAK-M expression limits dendritic cell activation and proinflammatory cytokine production in response to Helicobacter pylori.
Shiu J; Czinn SJ; Kobayashi KS; Sun Y; Blanchard TG
PLoS One; 2013; 8(6):e66914. PubMed ID: 23776703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
